JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makover, A.
Right arrow Articles by Goodman, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makover, A.
Right arrow Articles by Goodman, D. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 263, Issue 18, 8598-8603, 06, 1988

Plasma transthyretin. Tissue sites of degradation and turnover in the rat

A Makover, H Moriwaki, R Ramakrishnan, MJ Saraiva, WS Blaner and DS Goodman
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032.

Transthyretin (TTR) is involved in the plasma transport of both retinol and thyroid hormones. TTR is synthesized in the liver and choroid plexus, and in small amounts in several other tissues. A study was conducted to determine the tissue sites of degradation and turnover of TTR in the rat. The study employed TTR labeled with tyramine cellobiose (TC) and the trapped ligand method. Samples of purified rat TTR were labeled either with 125I-TC or directly with 131I. A mixture of the two labeled TTRs was injected intravenously into six rats. Blood samples were collected via a venous catheter for kinetic (turnover) analysis. After 24 or 48 h, the rats were killed, and 23 different tissues/organs were assayed as possible sites of TTR degradation. Derivatization of TTR with TC did not appreciably alter TTR plasma kinetics. Plasma turnover data were best fit by a three-pool model. The mean fractional turnover of plasma TTR was 0.15/h, and of total body TTR 0.04/h. The major sites of TTR degradation were the liver (36-38% of total body TTR degradation, almost all in hepatocytes), muscle (12-15%), and skin (8- 10%). Tissues that were sites of 1-8% of body TTR degradation included kidneys, adipose tissue, testes, and the gastrointestinal tract. Less than 1% of total TTR degradation occurred in the other tissues examined. A second study was conducted in which labeled TTR was injected intraventricularly into the cerebrospinal fluid in order to explore the degradation of TTR of choroid plexus origin. The kinetics of the appearance and disappearance of such labeled TTR in plasma were physiologically reasonable, with an estimated turnover of cerebrospinal fluid TTR of the order of 0.33/h. The major tissue sites of degradation of labeled TTR injected into cerebrospinal fluid and into plasma were approximately the same. No specific degradation of TTR was found in the nervous system tissues. The most active organs of TTR catabolism, per gram wet weight, were liver and kidneys. These studies demonstrate that many tissues participate in TTR turnover and degradation; the studies provide quantitative information about the tissue sites of TTR catabolism.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
R. E. Steward, R. S. Armen, and V. Daggett
Different disease-causing mutations in transthyretin trigger the same conformational conversion
Protein Eng. Des. Sel., March 1, 2008; 21(3): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ghiso, M. Shayo, M. Calero, D. Ng, Y. Tomidokoro, S. Gandy, A. Rostagno, and B. Frangione
Systemic Catabolism of Alzheimer's A{beta}40 and A{beta}42
J. Biol. Chem., October 29, 2004; 279(44): 45897 - 45908.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. D. Li, J. K. Kane, S. G. Matta, W. S. Blaner, and B. M. Sharp
Nicotine Enhances the Biosynthesis and Secretion of Transthyretin from the Choroid Plexus in Rats: Implications for beta -Amyloid Formation
J. Neurosci., February 15, 2000; 20(4): 1318 - 1323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. B. Kurlandsky, M. V. Gamble, R. Ramakrishnan, and W. S. Blaner
Plasma Delivery of Retinoic Acid to Tissues in the Rat
J. Biol. Chem., July 28, 1995; 270(30): 17850 - 17857.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Sousa, A. G. W. Norden, C. Jacobsen, T. E. Willnow, E. I. Christensen, R. V. Thakker, P. J. Verroust, S. K. Moestrup, and M. J. Saraiva
Evidence for the Role of Megalin in Renal Uptake of Transthyretin
J. Biol. Chem., December 1, 2000; 275(49): 38176 - 38181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Sousa and M. J. Saraiva
Internalization of Transthyretin. EVIDENCE OF A NOVEL YET UNIDENTIFIED RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE RECEPTOR
J. Biol. Chem., April 20, 2001; 276(17): 14420 - 14425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.